Impact of carbamylation on three different methods, HPLC, capillary electrophoresis and TINIA of measuring HbA1c levels in patients with kidney disease
- 1 April 2015
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 108 (1) , 15-22
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Measurement of Hba1C in patients with chronic renal failureClinica Chimica Acta, 2013
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participantsThe Lancet, 2011
- A1C Level and Future Risk of Diabetes: A Systematic ReviewDiabetes Care, 2010
- International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of DiabetesDiabetes Care, 2009
- Translating the A1C AssayDiabetes Care, 2008
- Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patientsKidney International, 1998
- Factors determining hemoglobin carbamylation in renal failureKidney International, 1995
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Hemoglobin Carbamylation in UremiaNew England Journal of Medicine, 1981
- On a Test of Whether one of Two Random Variables is Stochastically Larger than the OtherThe Annals of Mathematical Statistics, 1947